- Home
- PETZ vs CABR Comparison
PETZ vs CABR Comparison
Compare PETZ & CABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PETZ | CABR |
|---|---|---|
| Founded | 2002 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 12.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | PETZ | CABR |
|---|---|---|
| Price | $1.13 | $0.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.0K | ★ 52.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.89 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $0.71 |
| 52 Week High | $1.68 | $1.65 |
Technical Indicators
Market Signals| Indicator | PETZ | CABR |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 49.65 |
| Support Level | $0.94 | $0.78 |
| Resistance Level | $1.20 | $1.08 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 79.37 | 42.75 |
Price Performance
Historical ComparisonAbout PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About CABR Caring Brands Inc.
Caring Brands Inc is a consumer wellness company that supports health and wellness through research and development. Its product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. The majority of revenue is generated from the sale of OTC and consumer products, as well as licensing royalties.